Xuetao Cao
Peking Union Medical College
537 Papers
5.2K Citations
Xuetao Cao is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Immune system & Biology. The author has an hindex of 95, co-authored 509 publications. Previous affiliations of Xuetao Cao include Transgene SA & Huazhong University of Science and Technology.
Chat about Author
Papers
A new cytosolic DNA-recognition pathway for DNA-induced inflammatory responses.
TL;DR: There is little insight on how cytosolic DNA induces activation of the transcription factor NF-κB, which is important for the DNA-triggered production of pro-IL-1β, TNF and IL-6.
DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells
Yingming Jiang,Tao Wan,Guoyou Chen,Fangming Xiu,Dajing Xia,Weiping Zhang,Xiangyang Zhou,Xuetao Cao,Xuetao Cao +8 more
TL;DR: A cadherin-like molecule DC-CLM was cloned from a human dendritic cell (DC) cDNA library and it may be a soluble cadher in the effector function of activated DC for tumor suppression.
3
A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques
Gu C,Xuetao Cao,Z.G. Wang,Xue Hu,Yu-Lin Yao,Ying Zhou,Peng Liu,Xin Liu,Ge Gao,Y. Zhang,Zuojia Chen,Gao L,Yousong Peng,Jia F,Chao Shan,Li Yu,Kui Liu,Ning Li,Wangxin Guo,Jiang G,Juan Min,Jun-Wu Zhang,Ling Yang,Shi M,Hou T,Youping Li,Wenhua Liang,Lu G,Chen Yang,Yungui Wang,Kun Xia,Xiao Z,Xue J,Xin Huang,Xi Chen,Ma Hongtu,Danfeng Song,Pan Z,Xiaodong Wang,Guo H,Hongwei Liang,Zhiming Yuan,Wuxiang Guan,Deng S +43 more
TL;DR: In this article, the authors identified two potent antibodies against SARS-CoV-2 RBD from antibody libraries using a phage-to-yeast (PtY) display platform in only 10 days.
3
In vivo gene therapy of murine melanoma mediated by recombinant vaccinia virus encoding human IL-2 gene.
TL;DR: The results suggest that in vivo transfection mediated by rVV-IL-2 has potential effectiveness in enhancing host immunity and would be a useful approach to cancer gene therapy.
3
Construction of the dicistronic adenovirus vector expressing bioactive human interleukin-12*
TL;DR: It is suggested that the dicistronic adenovirus vector of hIL-12 could effectively mediate the expression of bioactive h IL-12 and might be used in cancer gene therapy.